1. In October–November 2024, Axomove became the second application (after Cureety) listed in France's reimbursable digital health applications directory (PECAN) by the national health authority, enabling reimbursement by French Social Security for patients with lower back pain.
2. On February 10, 2026, Bpifrance launched the €100 million Digital Prevention Fund; Axomove became its inaugural investment.
3. In April 2026, Axomove closed a €4 million Series A funding round co-led by the Digital Prevention Fund managed by Bpifrance and Go Capital, alongside Inco Ventures and historical investor Faraday Venture Partners.
Company Profile (Updated April 2026)
Axomove is a French digital health company headquartered in Lille, France. Founded in 2019 by four co-founders — Boris Lévêque, Clément Morel, Alexandre Morel, and Pierre-Yves Carlier — the company develops a digital medical device platform for the prevention and rehabilitation of musculoskeletal disorders (MSDs). Axomove combines personalized video exercise programs, teleconsultation, and remote medical monitoring to support patients from hospital discharge through home recovery, while also offering workplace prevention programs for corporate clients. The platform is built on a ISO 13485-certified quality management system and carries a CE mark as a medical device.
Development History:
- 2019: Axomove founded in Lille with the mission of helping physiotherapists in their practice
- March 2019: Launched the hospital offer for rehabilitation centers and hospitals; first customer was the Espoir centre in Lille
- April 2019: Reached 1,000 registered patients shortly after commercial launch
- December 2019: Launched a digital MSK prevention offer for companies and employees; first corporate customers included Danone, France Télévision, and Bonduelle
- April 2020: Made the platform available free of charge to all rehabilitation professionals during the COVID-19 pandemic to ensure continuity of care
- September 2020: Reached 1,000 healthcare professional users including physiotherapists, PRM doctors, rheumatologists, occupational therapists, and sports physicians
- January 2022: Signed first partnership with an international insurer (Allianz), integrating Axomove into provident contracts for MSK prevention
- 2022: Raised €1.6 million led by Faraday Venture Partners, alongside Santélys and Groupe JLO
- February 2022: Certified its digital medical device Axomove Therapy as a Class MD (Medical Device) manufacturer
- October–November 2024: Listed in France's reimbursable digital health applications directory (PECAN), enabling French Social Security reimbursement for lower back pain patients
- April 2026: Raised €4 million Series A to accelerate commercialization and expand reimbursement coverage
Core Mission: To democratize access to high-quality, personalized musculoskeletal prevention and rehabilitation through digital technology, improving patient functional outcomes while reducing absenteeism and healthcare costs for employers and the healthcare system.
Series A Funding (April 2026)
Transaction Overview
Amount: €4 million
Round: Series A
Co-Lead Investors: Digital Prevention Fund (managed by Bpifrance, launched February 10, 2026) and Go Capital
Participating Investors: Inco Ventures; Faraday Venture Partners (historical investor, reinforcing commitment since 2022)
Total Funding Raised: Approximately €5.6 million (€1.6M in 2022 + €4M in 2026)
Strategic Priorities for Funds:
- Strengthen the commercial development of the offering with companies, insurers, and healthcare institutions
- Extend reimbursement to all musculoskeletal diseases as well as metabolic diseases, including obesity
- Enrich the technology platform to improve the user experience through advanced features such as motion capture and gamification
Leadership Quotes:
- Boris Lévêque, Co-founder and CEO of Axomove: ＂The confidence of leading institutional investors testifies to the relevance of our strategy and reinforces our ambition to become a standard of care in prevention and rehabilitation.＂
- Jean-Briac Lesné, Senior Investment Director at Bpifrance: ＂Axomove is the first investment of the Digital Prevention Fund managed by Bpifrance. It fully illustrates our strategy: to support the deployment of innovative solutions that contribute concretely to prevention in real-world conditions and whose medical-economic impact strengthens the efficiency of the health system by reducing avoidable expenses.＂
- Anne Toupé, Investment Director at Go Capital: ＂We were convinced by Axomove's positioning on a key public health issue and by the robustness of its model. Its ability to combine clinical impact and economic efficiency makes it a player with strong potential. We are delighted to support the team in this new phase of growth.＂
- Gonzalo Tradacete, CEO and Founder of Faraday Venture Partners: ＂Since our entry in 2022, Axomove has demonstrated very strong execution capabilities, validating its proposition both clinically and commercially. The combination of a digital solution and healthcare support is effectively addressing a structural issue, such as musculoskeletal disorders, with tangible impact on patients and companies.＂
Core Products ＆ Platform
Axomove Digital Medical Device
Axomove Therapy (Certified MD, ISO 13485, CE Marked):
- Personalized Exercise Programs: 1,500+ video-based physical exercises designed by physiotherapy experts, customized to each patient's condition and recovery stage
- Teleconsultation: Remote video consultations with healthcare professionals via integrated camera and movement expertise tools
- Remote Monitoring: Digital telemonitoring of patient adherence, progress, and functional improvement throughout the care pathway
- Prevention Module: Digital clinic for corporate employees focusing on MSK prevention at work, with tailored content and new features for occupational health
Target Pathologies
- Current Reimbursed Indication: Lower back pain (reimbursed by French Social Security since October–November 2024)
- Planned Expansion: Additional musculoskeletal conditions and metabolic diseases, with a specific focus on obesity
Clinical ＆ Economic Outcomes
Validated Performance Metrics
- Functional Capacity: Doubling of patient functional capacity
- Treatment Adherence: Fivefold increase in treatment adherence compared to traditional rehabilitation
- Absenteeism Reduction: 50% reduction in workplace absenteeism for corporate users
- Healthcare Cost Savings: Healthcare costs cut by two-thirds (threefold decrease) for covered populations
- Pain Reduction: Client case studies show 55–82% pain reduction for platform users
Market Presence ＆ Client Base
Key Metrics (2026)
- Clients: 150 B2B clients across hospitals, corporations, and insurers
- Users: 75,000 active users on the platform
- Workforce: 30 professionals (planning to double over the next three years)
Notable Clients ＆ Partners
- Corporate: Air France, Thales, Danone, France Télévision, Bonduelle
- Insurance: Allianz, Alliance Klesia-Generali
- Healthcare Providers: CHU de Lille, Ramsay Santé, Espoir centre (Lille), CHU de Reims, MGEN/Vyv3 clinics
International Initiatives
Ukraine Rehabilitation Support (FASEP)
- Axomove is participating in a French Treasury-funded FASEP project to provide a therapeutic digital rehabilitation device for war victims in Ukraine
- The demonstrator project supports the Unbroken hospital complex in Lviv, where tens of thousands of injured Ukrainians await rehabilitation care and orthopaedic devices
- At least 85% of the project's added value is guaranteed to be generated in France, in accordance with FASEP eligibility criteria
Company Information
Corporate Overview
Company Name: Axomove
Founded: 2019
Headquarters: Lille, France
Legal Status: Private company
Industry: Digital Health / Healthcare Technology Systems / Remote Rehabilitation
Employees: 30 (as of April 2026)
Total Funding Raised: Approximately €5.6 million (€1.6M in 2022 + €4M Series A in 2026)
Leadership
Co-founder ＆ CEO: Boris Lévêque
- Co-founded Axomove in 2019; leads company strategy and investor relations
- Former professional handball player and Decathlon product manager with deep experience in musculoskeletal braces
Co-founders:
- Clément Morel: Previously led Axomove as CEO and represented the company at MedFIT 2024
- Alexandre Morel: Biotech PhD; serves as CTO
- Pierre-Yves Carlier: Specialized physiotherapist ensuring clinical rigor of platform content
Competitive Landscape
Key Competitors (Remote Rehabilitation)
- SWORD Health (Portugal): Tech-enabled MSK care pairing licensed physical therapists with innovative technology
- Hinge Health (USA): Digital MSK clinic offering full-service physical medicine and rehabilitation
- RecoveryOne / OneStep (USA): Remote therapeutic monitoring and MSK condition management
- Rebee Health (Singapore): Digital physiotherapy with wearable sensor technology
- MyRecovery (UK): App-based support for orthopaedic patients and care optimization
Axomove's Competitive Advantages
- National Reimbursement: One of only two applications listed in France's reimbursable digital health directory (PECAN), providing sustainable revenue through Social Security
- Clinical Validation: Measurable outcomes: 2x functional capacity, 5x adherence, 50% absenteeism reduction, 2/3 cost decrease
- B2B2C Model: Strong traction across all three segments: hospitals, corporations, and insurers
- MD Certification: ISO 13485-certified and CE-marked digital medical device since 2022, ensuring regulatory compliance and clinical credibility
- Institutional Backing: Supported by prominent French and European investors including Bpifrance and Go Capital; inaugural investment of the €100M Digital Prevention Fund
- Social Impact: Active participation in international humanitarian health initiatives (Ukraine FASEP project)
2026 Outlook ＆ Strategic Priorities
Growth Strategy
- Reimbursement Expansion: Extend Social Security coverage from lower back pain to additional musculoskeletal and metabolic conditions, with obesity as a priority target
- Technology Enhancement: Integrate advanced motion capture and gamification features to improve user experience and adherence
- Workforce Scaling: Double the team size over the next three years to support commercial and product development
- Corporate Penetration: Deepen relationships with existing enterprise clients (Air France, Thales, Allianz) and expand to new corporate and insurance partners
- International Development: Leverage French Healthcare Association networks and FASEP partnerships to explore export opportunities; target expatriate populations through international insurers like MSH
Contact Information
Headquarters
Location: Lille, France
Website: www.axomove.com
Keywords: Axomove,digital health,tele-rehabilitation,musculoskeletal disorders,MSD,remote physiotherapy,prevention,rehabilitation,Lille,France,2019,Boris Leveque,Clément Morel,Alexandre Morel,Pierre-Yves Carlier,Series A,Bpifrance,Go Capital,Inco Ventures,Faraday Venture Partners,Santélys,Groupe JLO,PECAN,reimbursable digital health application,ISO 13485,CE mark,Axomove Therapy,Air France,Thales,Allianz,Alliance Klesia-Generali,Ramsay Santé,CHU de Lille,CHU de Reims,lower back pain,obesity,metabolic diseases,FASEP,Ukraine
